Thomas Maciag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thomas Maciag has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Anna Mandinova
Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA
5 shared publicationsIgor Prudovsky
Center for Molecular Medicine, Maine Medical Center Research Institute,Scarborough, ME 04074, USA
5 shared publicationsRaffaella Soldi
Center for Molecular Medicine, Maine Medical Center Research Institute,Scarborough, ME 04074, USA
5 shared publicationsStephen Bellum
Center for Molecular Medicine, Maine Medical Center Research Institute,Scarborough, ME 04074, USA
4 shared publicationsCinzia Bagala
Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074
3 shared publicationsFrancesca Tarantini
Department of Geriatric Medicine, University of Florence, School of Medicine,Florence 50139, Italy
2 shared publications
Latest Publications
- 28 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (4) , 1041-1047
The alternative translation of synaptotagmin 1 mediates the non-classical release of FGF1
- 28 September 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 310 (4) , 1041-1047
The alternative translation of synaptotagmin 1 mediates the non-classical release of FGF1
- Open Access
- 1 July 2003
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 116 (13) , 2687-2696
S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells
Copper is involved in the promotion of angiogenic and inflammatory events in vivo and, although recent clinical data has demonstrated the potential of Cu2+ chelators for the treatment of cancer in man, the mechanism for this activity remains unknown. We have previously demonstrated that the signal peptide-less angiogenic polypeptide, FGF1, uses intracellular Cu2+ to facilitate the formation of a multiprotein aggregate that enables the release of FGF1 in response to stress and that the expression of the precursor form but not the mature form of IL-1α represses the stress-induced export of FGF1 from NIH 3T3 cells. We report here that IL-1α is a Cu2+-binding protein and human U937 cells, like NIH 3T3 cells, release IL-1α in response to temperature stress in a Cu2+-dependent manner. We also report that the stress-induced export of IL-1α involves the intracellular association with the Cu2+-binding protein, S100A13. In addition, the expression of a S100A13 mutant lacking a sequence novel to this gene product functions as a dominant-negative repressor of IL-1α release, whereas the expression of wild-type S100A13 functions to eliminate the requirement for stress-induced transcription. Lastly, we present biophysical evidence that IL-1α may be endowed with molten globule character, which may facilitate its release through the plasma membrane. Because Cu2+ chelation also represses the release of FGF1, the ability of Cu2+ chelators to potentially serve as effective clinical anti-cancer agents may be related to their ability to limit the export of these proinflammatory and angiogenic signal peptide-less polypeptides into the extracellular compartment.
- 1 July 2003
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 116 (13) , 2687-2696
Open AccessS100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells
Copper is involved in the promotion of angiogenic and inflammatory events in vivo and, although recent clinical data has demonstrated the potential of Cu2+ chelators for the treatment of cancer in man, the mechanism for this activity remains unknown. We have previously demonstrated that the signal peptide-less angiogenic polypeptide, FGF1, uses intracellular Cu2+ to facilitate the formation of a multiprotein aggregate that enables the release of FGF1 in response to stress and that the expression of the precursor form but not the mature form of IL-1α represses the stress-induced export of FGF1 from NIH 3T3 cells. We report here that IL-1α is a Cu2+-binding protein and human U937 cells, like NIH 3T3 cells, release IL-1α in response to temperature stress in a Cu2+-dependent manner. We also report that the stress-induced export of IL-1α involves the intracellular association with the Cu2+-binding protein, S100A13. In addition, the expression of a S100A13 mutant lacking a sequence novel to this gene product functions as a dominant-negative repressor of IL-1α release, whereas the expression of wild-type S100A13 functions to eliminate the requirement for stress-induced transcription. Lastly, we present biophysical evidence that IL-1α may be endowed with molten globule character, which may facilitate its release through the plasma membrane. Because Cu2+ chelation also represses the release of FGF1, the ability of Cu2+ chelators to potentially serve as effective clinical anti-cancer agents may be related to their ability to limit the export of these proinflammatory and angiogenic signal peptide-less polypeptides into the extracellular compartment.
- 16 May 2003
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (11) , 6700-6705
Copper chelation represses the vascular response to injury
The induction of an acute inflammatory response followed by the release of polypeptide cytokines and growth factors from peripheral blood monocytes has been implicated in mediating the response to vascular injury. Because the Cu 2 + -binding proteins IL-1α and fibroblast growth factor 1 are exported into the extracellular compartment in a stress-dependent manner by using intracellular Cu 2 + to facilitate the formation of S100A13 heterotetrameric complexes and these signal peptideless polypeptides have been implicated as regulators of vascular injury in vivo , we examined the ability of Cu 2 + chelation to repress neointimal thickening in response to injury. We observed that the oral administration of the Cu 2 + chelator tetrathiomolybdate was able to reduce neointimal thickening after balloon injury in the rat. Interestingly, although immunohistochemical analysis of control neointimal sections exhibited prominent staining for MAC1, IL-1α, S100A13, and the acidic phospholipid phosphatidylserine, similar sections obtained from tetrathiomolybdate-treated animals did not. Further, adenoviral gene transfer of the IL-1 receptor antagonist during vascular injury also significantly reduced the area of neointimal thickening. Our data suggest that intracellular copper may be involved in mediating the response to injury in vivo by its ability to regulate the stress-induced release of IL-1α by using the nonclassical export mechanism employed by human peripheral blood mononuclear cells in vitro .
- 16 May 2003
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (11) , 6700-6705
Copper chelation represses the vascular response to injury
The induction of an acute inflammatory response followed by the release of polypeptide cytokines and growth factors from peripheral blood monocytes has been implicated in mediating the response to vascular injury. Because the Cu 2 + -binding proteins IL-1α and fibroblast growth factor 1 are exported into the extracellular compartment in a stress-dependent manner by using intracellular Cu 2 + to facilitate the formation of S100A13 heterotetrameric complexes and these signal peptideless polypeptides have been implicated as regulators of vascular injury in vivo , we examined the ability of Cu 2 + chelation to repress neointimal thickening in response to injury. We observed that the oral administration of the Cu 2 + chelator tetrathiomolybdate was able to reduce neointimal thickening after balloon injury in the rat. Interestingly, although immunohistochemical analysis of control neointimal sections exhibited prominent staining for MAC1, IL-1α, S100A13, and the acidic phospholipid phosphatidylserine, similar sections obtained from tetrathiomolybdate-treated animals did not. Further, adenoviral gene transfer of the IL-1 receptor antagonist during vascular injury also significantly reduced the area of neointimal thickening. Our data suggest that intracellular copper may be involved in mediating the response to injury in vivo by its ability to regulate the stress-induced release of IL-1α by using the nonclassical export mechanism employed by human peripheral blood mononuclear cells in vitro .
- Open Access
- 1 May 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (18) , 16405-16413
Notch Activation Suppresses Fibroblast Growth Factor-dependent Cellular Transformation
- 1 May 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (18) , 16405-16413
Open AccessNotch Activation Suppresses Fibroblast Growth Factor-dependent Cellular Transformation
- Open Access
- 22 July 2002
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 158 (2) , 201-208
The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export
The release of signal peptideless proteins occurs through nonclassical export pathways and the release of fibroblast growth factor (FGF)1 in response to cellular stress is well documented. Although biochemical evidence suggests that the formation of a multiprotein complex containing S100A13 and Synaptotagmin (Syt)1 is important for the release of FGF1, it is unclear where this intracellular complex is assembled. As a result, we employed real-time analysis using confocal fluorescence microscopy to study the spatio-temporal aspects of this nonclassical export pathway and demonstrate that heat shock stimulates the redistribution of FGF1 from a diffuse cytosolic pattern to a locale near the inner surface of the plasma membrane where it colocalized with S100A13 and Syt1. In addition, coexpression of dominant-negative mutant forms of S100A13 and Syt1, which both repress the release of FGF1, failed to inhibit the stress-induced peripheral redistribution of intracellular FGF1. However, amlexanox, a compound that is known to attenuate actin stress fiber formation and FGF1 release, was able to repress this process. These data suggest that the assembly of the intracellular complex involved in the release of FGF1 occurs near the inner surface of the plasma membrane and is dependent on the F-actin cytoskeleton.
- 22 July 2002
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 158 (2) , 201-208
Open AccessThe intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export
The release of signal peptideless proteins occurs through nonclassical export pathways and the release of fibroblast growth factor (FGF)1 in response to cellular stress is well documented. Although biochemical evidence suggests that the formation of a multiprotein complex containing S100A13 and Synaptotagmin (Syt)1 is important for the release of FGF1, it is unclear where this intracellular complex is assembled. As a result, we employed real-time analysis using confocal fluorescence microscopy to study the spatio-temporal aspects of this nonclassical export pathway and demonstrate that heat shock stimulates the redistribution of FGF1 from a diffuse cytosolic pattern to a locale near the inner surface of the plasma membrane where it colocalized with S100A13 and Syt1. In addition, coexpression of dominant-negative mutant forms of S100A13 and Syt1, which both repress the release of FGF1, failed to inhibit the stress-induced peripheral redistribution of intracellular FGF1. However, amlexanox, a compound that is known to attenuate actin stress fiber formation and FGF1 release, was able to repress this process. These data suggest that the assembly of the intracellular complex involved in the release of FGF1 occurs near the inner surface of the plasma membrane and is dependent on the F-actin cytoskeleton.
- 26 October 2001
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 89 (9) , 747-749
The Putative Convergent and Divergent Natures of Angiogenesis and Arteriogenesis
- 26 October 2001
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 89 (9) , 747-749
The Putative Convergent and Divergent Natures of Angiogenesis and Arteriogenesis
- Open Access
- 1 January 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (27) , 25549-25557
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of Fibroblast Growth Factor 1 in Response to Stress
- 1 January 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (27) , 25549-25557
Open AccessCopper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of Fibroblast Growth Factor 1 in Response to Stress